Effect of Photofrin-mediated photocytotoxicity on a panel of human pancreatic cancer cells

Photodiagnosis Photodyn Ther. 2013 Sep;10(3):244-251. doi: 10.1016/j.pdpdt.2012.11.001. Epub 2013 Jan 30.

Abstract

Background and objective: Pancreatic cancer is a leading cause of cancer-related deaths in men and women. Early clinical studies suggest that photodynamic therapy (PDT) might be a useful modality in the management of this deadly disease. In this study, the photocytotoxicity of Photofrin-mediated PDT on different human pancreatic cancer cells (BxPc-3, HPAF-II, Mia PaCa-2, MPanc-96, PANC-1 and PL-45) was examined.

Materials and methods: After co-incubating cancer cells with Photofrin (0-10 μg/ml) for 4h, the cells were irradiated with 0-6J/cm(2) of 630 nm light. The effect of Photofrin PDT on the survival of cells were examined using tetrazolium-based colorimetric assay and clonogenic assay. PDT-induced apoptosis was analyzed by flow cytometry. Expressions of apoptosis-related proteins were determined by western blot analysis.

Results: Photofrin PDT strongly inhibited the survival of pancreatic cancer cells. A small portion of cells (<15%) underwent apoptosis 24h after PDT at LD50. Cleavage of caspase-3, caspase-8, caspase-9 and PARP after PDT were also confirmed. BxPc-3, Mia PaCa-2, MPanc-96, and PANC-1 cells were more sensitive and HPAF-II and PL-45 cells less sensitive.

Conclusion: Photofrin PDT can induce apoptosis and inhibit survival of human pancreatic cancer cells.

Keywords: Apoptosis; Pancreatic cancer cells; Photodynamic therapy; Photofrin.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis / drug effects*
  • Cell Line, Tumor
  • Cell Survival / drug effects
  • Dihematoporphyrin Ether / therapeutic use*
  • Humans
  • Pancreatic Neoplasms / drug therapy*
  • Pancreatic Neoplasms / pathology*
  • Photochemotherapy / methods*
  • Photosensitizing Agents / therapeutic use*
  • Treatment Outcome

Substances

  • Photosensitizing Agents
  • Dihematoporphyrin Ether